Department of Nursing, Doctoral Course, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
College of Nursing, Aichi Medical University, 1-1, Yazakokarimata, Nagakute-city, Aichi Pref., 480-1195, Japan.
Support Care Cancer. 2022 Apr;30(4):3201-3213. doi: 10.1007/s00520-021-06728-2. Epub 2022 Jan 1.
We investigated the experiences of Japanese men with sexual dysfunction associated with various prostate cancer treatments.
We included 38 Japanese men who underwent the following initial treatments for prostate cancer: radical prostatectomy (n = 10), external beam radiotherapy (n = 12), brachytherapy (n = 5), and androgen deprivation therapy (n = 11). Semi-structured interviews were conducted regarding sexual dysfunction associated with prostate cancer treatment. Data were analyzed using a content analysis method. To obtain a unique experience for each treatment, we confirmed and organized the treatment method from which the code that constituted each category was derived. The category reliability was calculated based on Scott's formula for the matching rate of the classification by three qualitative researchers. The criterion for good reliability was set at 70%.
Japanese men with sexual dysfunction associated with prostate cancer treatments experienced the following: a desire to maintain sexual function and conflict in decision-making concerning the initial treatment for prostate cancer; a loss of values related to sexual dysfunction; an uncertainty regarding the consequences of sexual dysfunction; a sense of calm with fewer adverse effects of sexual dysfunction at the early treatment stage; an effort to accept sexual dysfunction; and management of their changed body at the later treatment stages. The concordance rates for the categories were 70% and 78%. Additionally, there were glimpses of experiences common to all treatments and trends in treatment-specific experiences.
It is necessary to provide care based on the experience of Japanese men with sexual dysfunction after prostate cancer treatment.
我们调查了日本男性在与各种前列腺癌治疗相关的性功能障碍方面的经历。
我们纳入了 38 名接受以下初始前列腺癌治疗的日本男性:根治性前列腺切除术(n=10)、外照射放疗(n=12)、近距离放疗(n=5)和雄激素剥夺疗法(n=11)。针对前列腺癌治疗相关的性功能障碍进行了半结构化访谈。使用内容分析法对数据进行分析。为了获得每种治疗方法的独特体验,我们从构成每个类别的代码来源中确认和组织了治疗方法。类别可靠性基于三位定性研究人员对分类的匹配率的 Scott 公式进行计算。良好可靠性的标准设定为 70%。
患有前列腺癌治疗相关性功能障碍的日本男性经历了以下情况:维持性功能的愿望以及在前列腺癌初始治疗决策方面的冲突;与性功能障碍相关的价值观丧失;对性功能障碍后果的不确定性;在早期治疗阶段性功能障碍的不良影响较少时的平静感;对性功能障碍的接受努力;以及在后期治疗阶段对身体变化的管理。类别之间的一致性率为 70%和 78%。此外,还存在所有治疗方法共同的体验迹象和治疗特异性体验的趋势。
有必要根据接受前列腺癌治疗后的日本男性的性功能障碍体验提供护理。